rg-101 (Regulus Therapeutics)
90
Structured Review
Regulus Therapeutics
rg-101
Rg 101, supplied by Regulus Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rg-101/rg+101/pm40562220-154-6-3
Average 90 stars, based on 1 article reviews
Rg 101, supplied by Regulus Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rg-101/rg+101/pm40562220-154-6-3
Average 90 stars, based on 1 article reviews
rg-101 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sequencing:Article Title: Antisense oligonucleotides as drugs with both direct and indirect antiviral actions. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications. Article Snippet: For example, Article Title: Trials and Tribulations of MicroRNA Therapeutics Article Snippet: RG-101: RG-101, an antagomir of Article Title: RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges Article Snippet: RG-101 , miR-122 , Article Title: The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Article Snippet: Miravirsen (produced by Roche/Santaris) and Article Title: Host-Targeting Antivirals for Chronic Viral Infections of the Liver. Article Snippet: For RG-101, reports about serious adverse effects, including jaundice and liver 523 toxicity, forced the FDA to place a clinical hold in 2016 ( Article Title: Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies. Article Snippet: INT-1B3 has its foundation in miR-193a-3p, a miRNA that, when downregulated, is linked to cancer, metastasis, and Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications Article Snippet: For example, Virus:Article Title: Antisense oligonucleotides as drugs with both direct and indirect antiviral actions. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications. Article Snippet: For example, Article Title: Trials and Tribulations of MicroRNA Therapeutics Article Snippet: RG-101: RG-101, an antagomir of Article Title: RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges Article Snippet: RG-101 , miR-122 , Article Title: The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Article Snippet: Miravirsen (produced by Roche/Santaris) and Article Title: Host-Targeting Antivirals for Chronic Viral Infections of the Liver. Article Snippet: For RG-101, reports about serious adverse effects, including jaundice and liver 523 toxicity, forced the FDA to place a clinical hold in 2016 ( Article Title: Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies. Article Snippet: INT-1B3 has its foundation in miR-193a-3p, a miRNA that, when downregulated, is linked to cancer, metastasis, and Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications Article Snippet: For example, Infection:Article Title: Antisense oligonucleotides as drugs with both direct and indirect antiviral actions. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications. Article Snippet: For example, Article Title: Trials and Tribulations of MicroRNA Therapeutics Article Snippet: RG-101: RG-101, an antagomir of Article Title: RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges Article Snippet: RG-101 , miR-122 , Article Title: The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS. Article Snippet: Miravirsen (produced by Roche/Santaris) and Article Title: Host-Targeting Antivirals for Chronic Viral Infections of the Liver. Article Snippet: For RG-101, reports about serious adverse effects, including jaundice and liver 523 toxicity, forced the FDA to place a clinical hold in 2016 ( Article Title: Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies. Article Snippet: INT-1B3 has its foundation in miR-193a-3p, a miRNA that, when downregulated, is linked to cancer, metastasis, and Article Title: Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications Article Snippet: For example, |